These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35572507)

  • 1. Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.
    Rosa GDS; Krieck AMT; Padula ET; Stievani FC; Rossi MC; Pfeifer JPH; Basso RM; Braz AMM; Golim MA; Alves ALG
    Front Immunol; 2022; 13():871216. PubMed ID: 35572507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility.
    Barrachina L; Cequier A; Romero A; Vitoria A; Zaragoza P; Vázquez FJ; Rodellar C
    Stem Cell Res Ther; 2020 Feb; 11(1):52. PubMed ID: 32028995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model.
    Williams LB; Koenig JB; Black B; Gibson TW; Sharif S; Koch TG
    Equine Vet J; 2016 Sep; 48(5):619-25. PubMed ID: 26114736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
    Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
    Vet Immunol Immunopathol; 2013 Nov; 156(1-2):99-106. PubMed ID: 24094688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.
    Ardanaz N; Vázquez FJ; Romero A; Remacha AR; Barrachina L; Sanz A; Ranera B; Vitoria A; Albareda J; Prades M; Zaragoza P; Martín-Burriel I; Rodellar C
    BMC Vet Res; 2016 Mar; 12():65. PubMed ID: 27029614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model.
    Joswig AJ; Mitchell A; Cummings KJ; Levine GJ; Gregory CA; Smith R; Watts AE
    Stem Cell Res Ther; 2017 Feb; 8(1):42. PubMed ID: 28241885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.
    Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
    Equine Vet J; 2020 Jul; 52(4):601-612. PubMed ID: 31821594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.
    Pezzanite LM; Fortier LA; Antczak DF; Cassano JM; Brosnahan MM; Miller D; Schnabel LV
    Stem Cell Res Ther; 2015 Apr; 6(1):54. PubMed ID: 25889095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.
    Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH
    Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
    Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
    Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.
    Carrade DD; Owens SD; Galuppo LD; Vidal MA; Ferraro GL; Librach F; Buerchler S; Friedman MS; Walker NJ; Borjesson DL
    Cytotherapy; 2011 Apr; 13(4):419-30. PubMed ID: 21105841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting.
    Rowland AL; Miller D; Berglund A; Schnabel LV; Levine GJ; Antczak DF; Watts AE
    Stem Cells Transl Med; 2021 May; 10(5):694-710. PubMed ID: 33369287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies.
    Berglund AK; Schnabel LV
    Equine Vet J; 2017 Jul; 49(4):539-544. PubMed ID: 27862236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro MSC function is related to clinical reaction in vivo.
    Rowland AL; Xu JJ; Joswig AJ; Gregory CA; Antczak DF; Cummings KJ; Watts AE
    Stem Cell Res Ther; 2018 Nov; 9(1):295. PubMed ID: 30409211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-donor antibody induction following intramuscular injections of allogeneic mesenchymal stromal cells.
    Alagesan S; Sanz-Nogués C; Chen X; Creane M; Ritter T; Ceredig R; O'Brien T; Griffin MD
    Immunol Cell Biol; 2018 May; 96(5):536-548. PubMed ID: 29446493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety.
    Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
    Equine Vet J; 2020 Jan; 52(1):144-151. PubMed ID: 31120574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cell and Cytokine Dynamics in the Blood of Patients after Hematopoietic Stem Cell Transplantation and Multipotent Mesenchymal Stromal Cell Administration.
    Petinati N; Davydova Y; Nikiforova K; Bigildeev A; Belyavsky A; Arapidi G; Drize N; Kuzmina L; Parovichnikova E; Savchenko V
    Transplant Cell Ther; 2023 Feb; 29(2):109.e1-109.e10. PubMed ID: 36372356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute synovitis and intra-articular methylprednisolone acetate in ponies.
    Todhunter RJ; Fubini SL; Vernier-Singer M; Wootton JA; Lust G; Freeman KP; MacLeod JN
    Osteoarthritis Cartilage; 1998 Mar; 6(2):94-105. PubMed ID: 9692064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous Synovial Mesenchymal Stem Cell Transplantation Suppresses Inflammation Caused by Synovial Harvesting and Promotes Healing in a Micro Minipig Repaired Meniscus Model.
    Ozeki N; Mizuno M; Yanada S; Okada T; Kubota R; Kushida Y; Furuoka H; Endo K; Katano H; Nakamura K; Ohya S; Koga H; Sekiya I
    Transplant Proc; 2023 Mar; 55(2):470-480. PubMed ID: 36906438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-articular opioid analgesia is effective in reducing pain and inflammation in an equine LPS induced synovitis model.
    van Loon JP; de Grauw JC; van Dierendonck M; L'ami JJ; Back W; van Weeren PR
    Equine Vet J; 2010 Jul; 42(5):412-9. PubMed ID: 20636777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.